Skip to content

Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02613728
Enrollment
32
Registered
2015-11-24
Start date
2016-05-13
Completion date
2022-03-08
Last updated
2022-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Colorectal cancer, Colorectal cancer surgery, Polyp(s), Accelerated Enhanced Recovery, RecoverMI, Fluid diary, Questionnaires, Surveys, RecoverMI device

Brief summary

The goal of this clinical research study is to learn if RecoverMI care can help to shorten the time that patients are in the hospital after surgery and if it can help them recover sooner. RecoverMI includes the following parts: * Preoperative Education * Early oral intake * Early mobilization * Telemedicine

Detailed description

Study Groups: If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one group is the same, better, or worse than the other group. * If you are assigned to Group 1, you will receive standard enhanced care after your surgery. * If you are assigned to Group 2, you will receive routine care after surgery, but you will also receive accelerated recovery, early discharge, and Telemedicine. Participants will be loaned an iPad to use for video-conferencing and text messaging in this study. This is an investigational study. The study doctor can explain how RecoverMI is designed to work. Up to 32 participants will be enrolled in this study. All will take part at MD Anderson.

Interventions

BEHAVIORALAccelerated Recovery Plan
BEHAVIORALEarly Discharge
OTHERTelemedicine
BEHAVIORALStandard Enhanced Care

Sponsors

American Society of Colon and Rectal Surgeons
CollaboratorOTHER
M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

1. Patient has histologically proven colorectal cancer or polyp(s) that is planned to be treated by surgical resection performed with curative intent. 2. Patient is \>/= 18 years and younger than 80 years. 3. Elective minimally invasive operation. 4. No planned ostomy creation at time of enrollment. 5. Serum creatinine \<1.5 measured within 30 days of surgery. 6. Ability to speak, read, and understand English.

Exclusion criteria

1. Strong, self-reported history of postoperative nausea and vomiting. 2. History of congestive heart failure. Systolic heart failure defined as Ejection Fraction (EF) \</= 40%), or diastolic heart failure defined as EF \>40% PLUS systemic manifestation of heart failure.

Design outcomes

Primary

MeasureTime frame
Cumulative Hospital Length of Stay (LOS)30 days post transplant

Secondary

MeasureTime frame
Failure Rate (FR) in the RecoverMI Arm30 days
Patient Satisfaction30 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026